The COVID-19 Pandemic and Enzyme Replacement Therapy in Lysosomal Storage Disorders
Aim:The coronavirus disease-2019 (COVID-19) pandemic has caused a worldwide public health emergency, especially affecting people with chronic illnesses including lysosomal storage disorders (LSDs). The unfavorable conditions due to COVID-19 have mostly affected people with chronic conditions, in ter...
Enregistré dans:
Auteurs principaux: | Asburçe Olgaç, Çiğdem Seher Kasapkara, Burak Açıkel, Yılmaz Yıldız, Gülhan Karakaya Molla, Mustafa Kılıç |
---|---|
Format: | article |
Langue: | EN TR |
Publié: |
Galenos Yayinevi
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e4ca6b06965e4c459c041dcca9d8acbe |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
par: Alícia Dorneles Dornelles, et autres
Publié: (2021) -
The Association Between Lysosomal Storage Disorder Genes and Parkinson’s Disease: A Large Cohort Study in Chinese Mainland Population
par: Yu-wen Zhao, et autres
Publié: (2021) -
Reproduction in Animal Models of Lysosomal Storage Diseases: A Scoping Review
par: Daniela Vuolo, et autres
Publié: (2021) -
A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases
par: Valentina La Cognata, et autres
Publié: (2021) -
El estudio HERS conmociona a la terapia de sustitución hormonal
par: Cano S,Antonio, et autres
Publié: (2000)